慢性阻塞性肺病中多频生物电阻分析的预后价值:系统性审查
Loredana-Crista Tiucă1,2, Gina Gheorghe1,2, Vlad Alexandru Ionescu1,2
1Faculty of Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.
Medicina (Kaunas, Lithuania)
|November 27, 2025
概括
多频生物电阻分析 (MF-BIA) 提供了慢性阻塞性肺病 (COPD) 的预后见解. 来自MF-BIA的相角 (PhA) 显示出预测死亡率和住院病例的前景,可能改善风险分层超出螺旋计.
科学领域:
- 肺部医学 肺部医学
- 生物医学工程 生物医学工程
- 临床营养学 临床营养学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种全身性疾病,身体组成和液体平衡显著影响预后.
- 螺旋计虽然对COPD诊断至关重要,但在反映不同患者结果方面存在局限性.
- 多频生物电阻分析 (MF-BIA) 提供了一种评估身体组成和流体状况的方法,提供潜在的预后信息.
研究的目的:
- 系统地审查MF-BIA在COPD患者的预后意义.
- 评估MF-BIA与关键临床结果的关联,包括死亡率,恶化和住院.
主要方法:
- 在PubMed,Web of Science和Scopus的系统文献搜索.
- 包括将MF-BIA参数与COPD患者的临床结果相关的研究.
- 由于异质性而导致数据的叙述综合;使用纽卡斯尔-太华尺度评估偏差风险.
主要成果:
- 八项研究被纳入了审查.
- 阶段角度 (PhA) 显示出一致的预后值,与死亡率和再入院相反相关.
- 无脂肪质量指数 (FFMI) 显示出不一致的独立预后值,液体分布参数由于潜在的混心脏因素需要仔细解释.
结论:
- MF-BIA,特别是PhA,在COPD中提供了有价值的预后信息.
- MF-BIA可能会增强风险分层,超出传统的螺旋计.
- 需要使用标准化方法进行进一步的前性研究,以确认MF-BIA在COPD的独立预后价值.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K


